Greg Mattingly, MD, founding partner of St. Charles Psychiatric Associates in St. Louis, Missouri and Associate Clinical Professor of Psychiatry, Washington University.

Interview courtesy:   Supernus Pharmaceuticals
Website for more information:   Qelbree.com

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common psychiatric diagnoses in adults that affects ~1 in 16 adults and 1 in 10 children in the U.S. The condition is defined as a persistent pattern of inattention and/or hyperactivity-impulsivity that can interfere with daily life.

ADHD symptoms can include inattention (like struggling to pay attention or stay organized), hyperactivity (like being restless or talking excessively) and impulsivity (like interrupting or acting without thinking). However, ADHD symptoms aren’t always universal, especially when it comes to men and women. These symptoms can have a serious impact on those living with it and can lead to people having a hard time performing daily activities or fulfilling work responsibilities because of symptoms.

Despite ADHD being a 24/7 chronic disorder, there are options for those living with the condition to help manage symptoms, which can include a combination of behavioral management techniques as well as medication. When it comes to treatment options, there is no one-size-fits-all, and sometimes it takes trying several treatment options to figure out which works. For people with ADHD, the first step is in recognizing symptoms and having open and honest conversations with a trusted healthcare provider.

To shed light on ADHD during the awareness month, Dr. Mattingly is available for interviews to discuss how ADHD can present, various treatment options, and relevant data for doctor-patient conversations. He can also speak to:

What ADHD is and how it is known to affect the brain

How men and women may experience ADHD differently, plus symptoms that are often overlooked

Ways for managing symptoms, whether for the individual or their family and loved ones

The evolving ADHD treatment landscape and updated information on how one non-stimulant treatment option interacts with the body

The post ADHD Awareness Month in October Living with the Condition & What to Know About Evolving Treatments, NOT ONLY FOR YOUNG PEOPLE! appeared first on Good News!.

STRUGGLE: Regaining Control From An Often Misunderstood And Misdiagnosed Skin Condition

The post STRUGGLE: Regaining Control From An Often Misunderstood And Misdiagnosed Skin Condition appeared first on Good News!.

A new survey revealed that adults and caregivers of children aged 2-17 years living with atopic dermatitis (AD), commonly referred to as eczema, experience sleep disruptions attributed to the condition’s hallmark symptom of itching, which negatively impacts their mood, decreases daytime productivity and heightens stress levels.

AD, one of the most common chronic inflammatory skin diseases, affects over 26 million people in the U.S. alone and up to 10% of adults worldwide. AD occurs most frequently in children, affecting up to 20% worldwide.

The prevalence of atopic dermatitis, an extremely burdensome skin condition that negatively impacts the quality of life of patients suffering from AD and the families and caretakers of patients with AD, continues to grow. Dr. John Browning, a pediatric dermatologist, believes that patients need meaningful solutions that go beyond the surface of the skin. This survey underscores how adults with AD and caregivers of children ages 2-17 years with AD feel about the current treatment landscape and their understanding of concerns related to using topical steroids. It also aimed to explore the extent to which AD symptoms disrupt sleep and, consequently, affect daily functioning for both AD patients and their caregivers.

Key findings from the survey among adult patients with AD (n=502) and caregivers of children 2-17 with AD (n=510):
Itch is a top frustration that impacts patients’ and caregivers’ ability to get quality sleep.

89% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis said itch is a top frustration from atopic dermatitis, and 94% said itching is the top symptom that disrupts sleep.

74% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis stated that atopic dermatitis frequently or occasionally impacts their ability to get quality sleep, and 76% claim they have disrupted sleep an average of one to four nights per week.

These sleep disruptions have negative effects on mood (69%), daily routines (54%), daytime focus (51%), daytime productivity (51%) and stress (50%).

A majority of patients apply topicals before bed to ensure a good night’s sleep, however, patients and caregivers of children with AD have concerns about current treatment options.

72% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis apply topicals before bed in an effort to ensure a good night’s sleep.

46% of caregivers of children aged 2-17 years with atopic dermatitis are extremely or very concerned about using topical steroids for their child’s atopic dermatitis.

Most patients and caregivers feel there should be a wider variety of treatment options.

Current topical treatments present issues that disrupt sleep, such as needing time to dry (58%), causing irritation (51%), and feeling uncomfortable (51%).

83% of adult patients and caregivers of children aged 2-17 years with atopic dermatitis said there is an unmet need in current atopic dermatitis treatment options.

Dr. Browning will discuss how itch (the hallmark symptom of atopic dermatitis), significantly disrupts sleep and the pressing need for new, long-term, treatment options to provide itch relief.

Interview is courtesy: Dermavant Sciences, Inc.
References available on request

#sleepawareness #march #sleeplessness #learnaboutcondition #johnbrowning #disruptions #impact #mood #productivity #stresslevels #dermavant #sciences #atopicdermatitis #ad

The post Sleep Awareness Month in March- Learn About Condition that Causes Sleeplessness appeared first on Good News!.

• WHAT: Imagine living with chronic pain that feels like hot coals burning in your skin and experiencing boils in some of your most intimate areas? For the estimated 1 in 100 people living with the debilitating skin condition called hidradenitis suppurativa (HS)*, it’s everyday life. “The Beacons: Illuminating HS Stories” will feature the stories of six people living with the condition, and how it impacts everything from their day to day life to relationships and beyond (you can watch the trailer here.) It is co-produced by advocate, journalist, and filmmaker Jasmine IVANNA Espy. The event will include a screening of the 30-minute film, followed by a panel discussion.
o About Hidradenitis suppurativa (HS): Hidradenitis suppurativa, or HS, is a condition that causes small, painful lumps to form under the skin, often where skin rubs together, such as the armpits, groin, buttocks, and breasts. The lumps heal slowly, recur, and can lead to tunnels under the skin and scarring. Once considered a rare condition, it is now thought that as many as 1 in 100 people are affected by HS.
o Those living with the condition struggle with more than their ability to feel confident, and it affects things like the ability to put clothes on, sit down, participate in their favorite hobbies, and pursue partnership and intimacy.

#jasmineivanna #producer #beacons #hidradenitissuppurativa #hs #filmmaker #illuminatinghsstories #skindisease #disfigure #painful #chronicpain

some more info, go to http://pausetheworldforpeace.org/2023/06/26/anthony-tony-yadao-vp-of-medical-affairs-for-immunology-novartis/

The post Documentary premiere at Tribeca Film Festival about 29-year old influencer, filmmaker and advocate Jasmine IVANNA Espy. She’s also the producer of “The Beacons: Illuminating HS Stories,” a new docuseries from Novartis that highlights her story and the stories of five other people living with hidradenitis suppurativa (HS) appeared first on Good News!.

One in five U.S. adults live with a mental illness. Some people living with a mental health condition may also experience an involuntary movement disorder called tardive dyskinesia (TD). TD is a chronic condition, associated with taking certain mental health medicines (antipsychotics) to treat conditions like depression, bipolar disorder, schizoaffective disorder, or anxiety disorder. It is unlikely to improve without treatment.
Approximately 600,000 people in the U.S. may be affected by TD, yet only approximately 25% have been diagnosed. The condition is characterized by uncontrollable, abnormal, and repetitive movements often seen in the face, torso, limbs, and fingers or toes. It can impact patients socially, emotionally, and physically–these movements can cause worry, frustration, and self-consciousness. According to a survey of 350 patients with diagnosed or suspected TD, patients reported the condition moderately or extremely affected them in the following areas:

Ability to work: 46%

Ability to sleep: 53%

Ability to eat & drink: 35%

Despite the number of people impacted by the condition, many people are still unfamiliar with TD. However, for patients living with the condition, their families, and their care partners it’s important to know they’re not alone.

As of this year, 50 states and Washington, D.C. and various advocacy groups have recognized Tardive Dyskinesia Awareness Week as the first full week of May (May 1-7, 2022) to support people in the U.S. with TD. May is also Mental Health Awareness Month, and as efforts are underway to increase awareness and support for those impacted by mental health conditions, it’s important to remember those living with a mental illness and taking antipsychotics for a prolonged time may develop or already have TD.

Dr. Rakesh Jain, Clinical Professor Department of Psychiatry, Texas Tech University School of Medicine, Austin, TX, will be available to discuss the emotional, physical, and social impact of TD as well as talk about the condition’s signs and symptoms. Dr. Jain will also explain how critical TD Awareness Week is to those living with a mental health condition and TD.

Interview courtesy: Neurocrine Biosciences

#maymentalhealthawareness #tardivedyskinesia #disorder #tdcondition #medicines #antipsychotics bipolardisorder #schizoaffectivedisorder #depression #anxietydisorder #treatment #abilitywork #abilutysleep #abilityeatdrink #neurocrinebiosciences #rakeshjain

The post May is Mental Health Awareness Month ***May (1-7) is Tardive Dyskinesia Awareness Week*** appeared first on Good News!.

HOLIDAYS CAN BE A DIFFICULT TIME FOR PEOPLE WITH OVERACTIVE BLADDER- WHAT HAVE YOU FOUND TO BE SOME OF THE MOST COMMON COMPLAINTS?

WHAT CAUSES OAB?

WHAT ARE SOME TECHNIQUES TO HELP MANAGE SYMPTOMS?

WHAT ELSE CAN PEOPLE DO ABOUT THIS CONDITION?

WHAT IS THE MAJOR TAKEAWAY YOU WANT OUR AUDIENCE TO REMEMBER?

Interview: Courtesy: Urovant Sciences

#diane #newman #nurse #oab #overactive #bladder #over #active #bothersome #holiday #season #health #condition #urology #treatment #sciences #managing #manage #bathroom #training

The post Surviving This Holiday Season with Overactive Bladder Are You Among the 1 in 10 Americans Impacted by Bothersome Overactive Bladder Symptoms? appeared first on Good News!.

Chronic pain is defined as pain that lasts longer than three months and can continue when the injury or illness has been treated. Chronic pain is a disabling condition that affects 100 million American adults every year, a number that keeps growing, which can negatively affect one’s wellbeing. Working, sleeping, or even seemingly simple tasks like walking up the stairs are activities that become harder if you’re living with chronic pain. In fact, chronic pain is one of the most common reasons adults seek medical care and costs the nation approximately $560-635 billion annually in direct medical treatment costs and lost productivity.

Michael Fishman, MD, MBA, double board-certified anesthesiologist and Interventional Pain Medicine specialist and his patient Genevieve Watycha, who suffered for more than 30 years with chronic pain, will be available to discuss the journey of chronic back pain management, including how Genevieve finally managed her chronic back pain, which had previously prevented her from sleeping properly, walking long distances and going about her day-to-day activities.

Three tips that may be helpful in managing chronic pain:
• Mind-Body Therapies: Mind-body therapies are treatments that are meant to help the mind’s ability to affect the functions and symptoms of the body. Mind-body therapies use various approaches including relaxation techniques, exercise, meditation, guided imagery, and hypnosis. Relaxation techniques can help alleviate discomfort related to chronic pain.
• Manage your diet: Believe it or not, diet has an impact on a person’s ability to fight pain away. Omega-3 fatty acids, found in foods such as salmon or tuna, have been known to reduce inflammation. Yellow, orange, and red fruits/vegetables are from a group of phytochemicals known as carotenoids – which have also been known to help reduce inflammation.
• Talk to your doctor about treatment options: In the case that medication or lifestyle changes won’t fix or lessen your pain, it’s crucial to speak to your doctor about the latest treatment options. Your doctor may recommend a number of treatments, including pharmacological, relaxation and/or physical therapy, or DTM Spinal Cord Stimulation, to help alleviate the pain.
Interview is courtesy: Medtronic
#chronic #pain #disease #backache #medtronic #disabling #condition #affect #working #sleeping #michael #fishman #genevieve #watycha #medicine #mind #body #therapy #diet #exercise

The post Chronic Pain: A Debilitating Disease Affecting 100 Million American Adults appeared first on Good News!.

STORIES OF INSPIRATION
During Holiday Season
https://www.hemlibra.com/

In recent years, people with hemophilia A have found hope thanks to important developments in the treatment of this bleeding disorder. For some living with this chronic condition, this may mean experiencing the coming holiday season with a new outlook on living with hemophilia A.

Guy is in his mid-30’s and was diagnosed with hemophilia A at birth. As a child, he experienced spontaneous brain bleeds at 18-months-old and again at three-years-old, which led to him becoming legally blind and experiencing seizures. Guy remembers going to the hospital multiple times a week for treatment and having over 20 surgeries. As a young adult, he avoided certain activities that might lead to a bleed.

Hemophilia A is a rare genetic bleeding disorder, typically diagnosed at a very young age, in which a person’s blood does not clot properly, leading to uncontrolled bleeding that can occur spontaneously. There are approximately 20,000 people who have hemophilia in the United States, with hemophilia A being the most common form.1,2 For people diagnosed with this rare condition, it can be a life-altering diagnosis. Even with treatment, hemophilia A can result in bleeds in muscles and joints that may lead to joint damage and chronic pain.2

People like Guy can face significant challenges managing their condition.3 After decades of accepting this as his normal, he began a different medicine that he takes once a month and has experienced fewer bleeds requiring treatment. Guy recently earned a master’s degree to pursue a career in strategic marketing. He has so much to celebrate this holiday season–it will be particularly special as his first as a newlywed after getting married in a small ceremony this past June.

Dr. Amy Shapiro, a hematologist-oncologist and Co-Founder of the Indiana Hemophilia and Thrombosis Center along with Guy Law, to discuss the impact this latest treatment continues to have for people living with hemophilia A.

Interview is courtesy: Genentech

1 Hemophilia Federation of America. Hemophilia A. https://www.hemophiliafed.org/understanding-bleeding-disorders/what-ishemophilia/hemophilia-a. Accessed October 12, 2020.
2 Mayo Clinic. Symptoms and Causes. https://www.mayoclinic.org/diseases-conditions/hemophilia/symptoms-causes/syc20373327. Accessed October 12, 2020.
3 Bauer, K. A. (2015). Current Challenges in the Management of Hemophilia. American Journal of Managed Care, 21(6).

#hemophilia #hemlibra #amy #shapiro #indiana #thrombosis #guy #law #hope #inspiration #holiday #season #bleeding #blood #disorder #chronic #condition #diagnosed #seizures #hospital #muscles #pain #oncologist #treatment #marketing #genentech #america

The post Hope for Those with Hemophilia appeared first on Good News!.

PUZZLING SKIN CONDITION AFFECTS MORE THAN MEETS THE EYE
THE HIDDEN REALITY OF LIVING WITH A CHRONIC SKIN DISEASE

Hidradenitis suppurativa (HS) is an under-recognized and chronic inflammatory skin condition caused by an overactive immune system that can often go undiagnosed or misdiagnosed for years. The symptoms of HS include recurrent, painful abscesses and lesions and can have a significant physical, mental and social impact. HS can be progressive and increase in severity over time.

HS also presents itself in sensitive areas like the armpits, groin and under the breasts and buttocks, so it may be hidden by clothing – leaving many to suffer in silence. Further, the lack of awareness around this disease may lead to patients going undiagnosed or misdiagnosed for seven or more years. Patients may visit a number of doctors before finding a dermatologist with experience in managing HS to confirm diagnosis and determine a plan that best fits their specific needs.

Dr. Joslyn Kirby, a dermatologist with Penn State University, will bring greater understanding about HS by sharing how it’s more than just an inflammatory skin disease. Dr. Kirby will also discuss the importance for HS patients – along with their caregivers – to advocate for their care and seek out a dermatologist with experience treating HS who can help patients to receive an accurate diagnosis and appropriate treatment options.

Interview courtesy: AbbVie Inc.

#november #healthy #skin #month #condition #meets #eyes #eye #chronic #disease #hidradenitis #suppurativa #hs #inflammatory #overactive #immune #system #undiagnosed #misdiagnosed #symptoms #recurrent #painful #abscesses #lesions #physical #mental #social #impact #increase #dermatologist #penn #state #university #psu #caregivers #treatment

The post NOVEMBER IS NATIONAL HEALTHY SKIN MONTH appeared first on Good News!.

Find Out More About this Condition. Capsian Patch, … can be considered. a specific approved product is Qutinza
More than 34 million Americans – just over 1 in 10 – have diabetes1, and neuropathic pain associated with diabetic peripheral neuropathy of the feet, or more commonly referred to as diabetic nerve pain, is one of its most common complications.2
The painful symptoms associated with this nerve damage include numbness, tingling, as well as shooting or stabbing sensations that most often affect the lower extremities.3
Itis a progressive and debilitating complication of diabetes that will affect approximately more than 5 million Americans in 20204 and is expected to double by 2030.5
Joining us now to discuss neuropathic pain associated with diabetic peripheral neuropathy – or diabetic nerve pain – and this newly approved treatment option is Dr. David Simpson, Professor of Neurology at the Icahn School of Medicine at Mount Sinai in New York City.
Key Facts and Figures:
• The lack of effective, innovative treatment options has left many patients with a significant unmet medical need.
• The condition is more common in patients with type 2 diabetes and increases with age and duration of disease.
When you book a window, we’ll provide you with guest bio & suggested questions. The interview is courtesy of Averitas Pharma, Inc.
References:
1. CDC Division of Diabetes Translation, National Diabetes Statistics Report, 2020. https://www.cdc.gov/diabetes/library/features/diabetes-stat-report.html#:~:text=New%20in%202020%2C%20the%20report,1%20in%203%E2%80%94have%20prediabetes. Accessed July 6, 2020
2. University of Chicago Center for Peripheral Neuropathy. Types of peripheral Neuropathy. http://peripheralneuropathycenter.uchicago.edu/learnaboutpn/typesofpn/diabetes/diabetes.shtml. Accessed July 6,2020
3. American Diabetes Association. Peripheral NeuorapthyOverview. https://www.diabetes.org/diabetes/complications/neuropathy/peripheral-neuropathy.Accessed July 17, 2020
4. LTP2020-2030: ADDRESSABLE POPULATIONS BY CONDITION (PDPN, PSNP, PHN, CINP).Company data on file. April 30, 2020.
5. Gore, M., Brandenburg, N. A., Dukes, E., Hoffman, D. L.,Tai, K.-S., & Stacey, B. (2005). Pain Severity in Diabetic Peripheral Neuropathy is Associated with patient Functioning, Symptom Levels of Anxiety and Depression, and Sleep. Journal of Pain and Symptom Management, 30(4),374-385. doi:10.1016/j.jpainsymman.2005.04.009.
https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html
6. CDC,Behavioral Risk Factor Surveillance System, 2018
7. America’sHealth Rankings. United Health Foundation.https://www.americashealthrankings.org/explore/annual/measure/Diabetes. Accessed July 13, 2020

The post DIABETIC NERVE PAIN WILL AFFECT APPROXIMATELY 5 MILLION AMERICANS IN 2020 appeared first on Good News!.